BW B1090U

Known as: BW-B 1090U, BW-B-1090U, BW-B1090U 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1988-1988
01219881988

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1989
1989
The in vitro rates of metabolism of mivacurium chloride and succinylcholine in pooled human plasma were compared. In addition… (More)
Is this relevant?
1989
1989
The dose-effect relationship of mivacurium chloride on arterial blood pressure, heart rate, and plasma histamine was determined… (More)
Is this relevant?
1989
1989
We determined the dose-response relationships of mivacurium (BW B1090U) in children (2-10 years) during nitrous oxide-halothane… (More)
Is this relevant?
1989
1989
Mivacurium chloride (BW B1090U) was administered to 72 patients during their elective surgery. The eight groups (nine subjects… (More)
Is this relevant?
1988
1988
Mivacurium chloride (BW B1090U) is a new, short-acting non-depolarizing neuromuscular blocking agent. It is a synthetic bis… (More)
  • table I
  • table II
  • table III
  • figure 1
Is this relevant?
1988
1988
Mivacurium chloride (BW B1090U), a bis-benzylisoquinolinium diester compound, was found to undergo hydrolysis in vitro by… (More)
Is this relevant?